Linked Data API

Show Search Form

Search Results

100021
star this property registered interest false more like this
star this property date less than 2014-10-15more like thismore than 2014-10-15
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Home Care Services more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, if he will bring forward proposals to facilitate the portability of home-based care packages between local authorities in different countries in the UK. more like this
star this property tabling member constituency Edinburgh East more like this
star this property tabling member printed
Sheila Gilmore more like this
star this property uin 905560 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-10-21more like thismore than 2014-10-21
unstar this property answer text <p>Adults with care and support needs should be able to move between countries within the United Kingdom knowing that their care will continue during the move.</p><p> </p><p> </p><p> </p><p>As the care and support systems in the four countries are different, we are developing principles with the Devolved Administrations to ensure continuity of care for people moving.</p><p> </p><p>These should be published in November.</p><p> </p> more like this
star this property answering member constituency North Norfolk remove filter
star this property answering member printed Norman Lamb more like this
star this property question first answered
less than 2014-10-21T15:45:44.866352Zmore like thismore than 2014-10-21T15:45:44.866352Z
star this property answering member
1439
star this property label Biography information for Norman Lamb more like this
star this property tabling member
3965
unstar this property label Biography information for Sheila Gilmore more like this
100024
star this property registered interest false more like this
star this property date less than 2014-10-15more like thismore than 2014-10-15
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Community Health Services: Devon more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, if he will increase funding from the Better Care Fund to improve the transition of community services in Devon. more like this
star this property tabling member constituency North Devon more like this
star this property tabling member printed
Sir Nick Harvey more like this
star this property uin 905558 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-10-21more like thismore than 2014-10-21
unstar this property answer text <p>The Better Care Fund is a pooled budget of £3.8 billion to be spent on integrating Health and Social care. Local areas will decide how best to use their funding to transform the provision of services to their communities, both improving outcomes for people, and driving efficiencies.</p><p> </p> more like this
star this property answering member constituency North Norfolk remove filter
star this property answering member printed Norman Lamb more like this
star this property question first answered
less than 2014-10-21T15:44:45.2891531Zmore like thismore than 2014-10-21T15:44:45.2891531Z
star this property answering member
1439
star this property label Biography information for Norman Lamb more like this
star this property tabling member
231
unstar this property label Biography information for Sir Nick Harvey more like this
100206
star this property registered interest false more like this
star this property date less than 2014-10-21more like thismore than 2014-10-21
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Compulsorily Detained Psychiatric Patients more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, whether any audits have been carried out since April 2012 which consider how many patients may have been detained under the Mental Health Act 1983 because a doctor had been influenced by the fact that doing so might make the provision of a bed for their patient more likely; and what were the findings of those audits. more like this
star this property tabling member constituency West Lancashire more like this
star this property tabling member printed
Rosie Cooper more like this
star this property uin 211396 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer remove maximum value filtermore like thismore than 2014-10-24
unstar this property answer text <p>The Care Quality Commission (CQC) is the regulator of the Mental Health Act 1983. In their annual report for 2012-13 <em>Monitoring the Mental Health Act in 2012/13</em>, published in January 2014, the CQC noted concerns raised by the House of Commons Health Committee over whether the Act’s powers of detention were being used improperly to access services. They said they found no direct evidence of unlawful practice.</p><p> </p><p> </p><p> </p><p>On 22 August 2014, the CQC published a series of reports relating to its inspection in May 2014 of services provided by Camden and Islington NHS Foundation Trust. The CQC found that that bed occupancy at the Trust averaged 96.4% between October and December last year, compared to the average of 85.9% across England. CQC inspectors were told that the pressures on beds meant that most new admissions to inpatient beds were people detained under the Act.</p><p> </p><p> </p><p> </p><p>The CQC’s annual report on the Act for 2013-14 is expected to be published early in 2015.</p><p> </p><p> </p><p> </p>
star this property answering member constituency North Norfolk remove filter
star this property answering member printed Norman Lamb more like this
star this property question first answered
less than 2014-10-24T11:27:05.1517044Zmore like thismore than 2014-10-24T11:27:05.1517044Z
star this property answering member
1439
star this property label Biography information for Norman Lamb more like this
star this property tabling member
1538
unstar this property label Biography information for Rosie Cooper more like this
48269
star this property registered interest false more like this
star this property date less than 2014-04-10more like thismore than 2014-04-10
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what discussions officials in his Department have had with the National Institute for Health and Care Excellence (NICE) on the development of NICE's highly specialised technologies programme since 1 January 2014; what the content of those discussions was; and if he will make a statement. more like this
star this property tabling member constituency Eddisbury more like this
star this property tabling member printed
Mr Stephen O'Brien more like this
star this property uin 196411 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-05-06more like thismore than 2014-05-06
unstar this property answer text <p>Departmental officials have had no such discussions. Officials may discuss individual highly specialised technology topics with the National Institute for Health and Care Excellence, including at the topic selection stage.</p> more like this
star this property answering member constituency North Norfolk remove filter
star this property answering member printed Norman Lamb more like this
star this property question first answered
less than 2014-05-06T12:00:00.00Zmore like thismore than 2014-05-06T12:00:00.00Z
star this property answering member
1439
star this property label Biography information for Norman Lamb more like this
star this property tabling member
427
unstar this property label Biography information for Mr Stephen O'Brien more like this
48274
star this property registered interest false more like this
star this property date less than 2014-04-10more like thismore than 2014-04-10
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what estimate his Department has made of the increase in demand for child and adolescent mental health following the launch of the MindEd e-portal; and what steps it is taking to accommodate that increase. more like this
star this property tabling member constituency Liverpool, Wavertree more like this
star this property tabling member printed
Luciana Berger more like this
star this property uin 196448 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-05-06more like thismore than 2014-05-06
unstar this property answer text <p>The Department has not made an estimate of the increase in demand for child and adolescent mental health following the launch of the MindEd e-portal on 25 March 2014.</p><p> </p><p>We know that many schools want to do more to help children who are, or may be, experiencing mental health problems. Many now have their own programmes and mental health support – such as a school-based counsellor, whilst others have whole school approaches to mental and emotional health. We want to ensure that such programmes offer the best support possible, but also that schools are better able to identify mental health problems in their pupils sooner.</p><p> </p><p>The Department funded the MindEd website which will help anyone working with children, including all school staff, to spot the signs of mental health problems in children and help them get the support they need. Spotting the signs of mental health problems early in children and young people is essential to prevent problems from escalating and continuing into adulthood.</p><p> </p><p>The Chief Medical Officer has recommended better data on children and young people's mental health. The Department, with arms lengths bodies (ALBs) and other key partners, is currently looking at the options available for arranging a survey of children and young people to look at prevalence of mental health conditions. We are seeking advice from colleagues in the Department's Health and Social Care Information Centre to consider options for the survey, and what such a survey would be able to tell us.</p><p> </p>
star this property answering member constituency North Norfolk remove filter
star this property answering member printed Norman Lamb more like this
star this property question first answered
less than 2014-05-06T12:00:00.00Zmore like thismore than 2014-05-06T12:00:00.00Z
star this property answering member
1439
star this property label Biography information for Norman Lamb more like this
star this property tabling member
4036
unstar this property label Biography information for Luciana Berger more like this
48276
star this property registered interest false more like this
star this property date less than 2014-04-10more like thismore than 2014-04-10
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, pursuant to the Answer of 24 March 2014, Official Report, column 120W, on haemolytic uraemic syndrome, what discussions NHS England has had with the National Institute for Health and Care Excellence (NICE) since 1 January 2014 on NICE's appraisal of eculizumab; and if he will make a statement. more like this
star this property tabling member constituency Eddisbury more like this
star this property tabling member printed
Mr Stephen O'Brien more like this
star this property uin 196426 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-05-06more like thismore than 2014-05-06
unstar this property answer text <p>We understand that NHS England was formally consulted on the scope of the National Institute for Health and Care Excellence's (NICE) evaluation of eculizumab for atypical haemolytic uraemic syndrome. NHS England was also consulted on the evaluation consultation document, which was published on 27 February.</p><p> </p><p>Following the publication of NICE's draft guidance on eculizumab, NICE sought further advice from NHS England on what considerations relating to the management of its specialised commissioning budget it considers should be taken into account in formulating a recommendation. The response from NHS England will be considered by NICE at the next meeting of the evaluation committee.</p><p> </p> more like this
star this property answering member constituency North Norfolk remove filter
star this property answering member printed Norman Lamb more like this
star this property question first answered
less than 2014-05-06T12:00:00.00Zmore like thismore than 2014-05-06T12:00:00.00Z
star this property answering member
1439
star this property label Biography information for Norman Lamb more like this
star this property tabling member
427
unstar this property label Biography information for Mr Stephen O'Brien more like this
48280
star this property registered interest false more like this
star this property date less than 2014-04-10more like thismore than 2014-04-10
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, pursuant to the Answer of 31 March 2014, Official Report, column 491W, on medical treatments, what technology appraisals were conducted by the National Institute for Health and Care Excellence in the last five years; what the most plausible cost per quality adjusted life-year for each such appraisal was; what the estimated eligible patient population was for each appraised indication; on which appraisals end-of-life criteria were applied in each final appraisal determination; and on which date each such appraisal was (a) initiated and (b) concluded. more like this
star this property tabling member constituency Eddisbury more like this
star this property tabling member printed
Mr Stephen O'Brien more like this
star this property uin 196429 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-05-06more like thismore than 2014-05-06
unstar this property answer text <p>National Institute for Health and Care Excellence (NICE) technology appraisal decisions published between 2000 to end of February 2014 have already been placed in the Library.</p><p> </p><p>NICE has advised that it does hold the most plausible cost per quality adjusted life-year for each technology appraisal, the estimated patient population for each appraised indication, details of appraisals where the end-of-life criteria were applied in each final appraisal determination and the dates each appraisal was initiated and concluded. However, this information could only be provided at disproportionate cost.</p><p> </p> more like this
star this property answering member constituency North Norfolk remove filter
star this property answering member printed Norman Lamb more like this
star this property question first answered
less than 2014-05-06T12:00:00.00Zmore like thismore than 2014-05-06T12:00:00.00Z
star this property answering member
1439
star this property label Biography information for Norman Lamb more like this
star this property tabling member
427
unstar this property label Biography information for Mr Stephen O'Brien more like this
48281
star this property registered interest false more like this
star this property date less than 2014-04-10more like thismore than 2014-04-10
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, if he will discuss with the National Institute for Health and Care Excellence (NICE) ensuring that assessments of treatments by NICE conducted through (a) normal technology appraisals and (b) highly specialised technology appraisals is consistent in its (i) engagement with stakeholders and (ii) wider methodological approaches. more like this
star this property tabling member constituency Eddisbury more like this
star this property tabling member printed
Mr Stephen O'Brien more like this
star this property uin 196428 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-05-06more like thismore than 2014-05-06
unstar this property answer text <p>We have no plans to do so. As an independent body, the National Institute for Health and Care Excellence is responsible for developing its methods and processes and applying them consistently.</p> more like this
star this property answering member constituency North Norfolk remove filter
star this property answering member printed Norman Lamb more like this
star this property question first answered
less than 2014-05-06T12:00:00.00Zmore like thismore than 2014-05-06T12:00:00.00Z
star this property answering member
1439
star this property label Biography information for Norman Lamb more like this
star this property tabling member
427
unstar this property label Biography information for Mr Stephen O'Brien more like this
48282
star this property registered interest false more like this
star this property date less than 2014-04-10more like thismore than 2014-04-10
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, how the National Institute for Health and Care Excellence (NICE) assesses the cost-effectiveness of an intervention when the data available are uncertain; what assessment NICE has made of the average range around the most-plausible cost-per-QALY in its technology appraisals; and if he will make a statement. more like this
star this property tabling member constituency Eddisbury more like this
star this property tabling member printed
Mr Stephen O'Brien more like this
star this property uin 196424 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-05-06more like thismore than 2014-05-06
unstar this property answer text <p>The National Institute for Health and Care Excellence (NICE) follows a rigorous process in the appraisal of technologies to ensure that judgements regarding the cost-effective use of NHS resources are consistently applied. This includes consideration of the uncertainty generated where available data have serious limitations.</p><p> </p><p>When making judgements on cost effectiveness, the NICE appraisal committee will consider a number of factors including the strength of the clinical-effectiveness evidence, the innovative nature of the technology, the robustness and plausibility of the economic models, the degree of certainty around the incremental cost-effectiveness ratio (ICER), the range and plausibility of the ICERs and the likelihood of decision error and its consequences. Full details of how the Committee takes uncertainty into account is contained within sections 5.8, 6.3 and 6.4 of NICE's Guide to the Methods of Technology Appraisal 2013, which is available at:</p><p>http://publications.nice.org.uk/guide-to-the-methods-of-technology-appraisal-2013-pmg9</p><p> </p><p>NICE advises that it has not carried out an assessment of the average range around the most plausible cost-per Quality Adjusted Life Year (QALY) in its technology appraisals. We understand that although NICE usually specifies the most plausible cost-per-QALY for each technology appraisal, it does not normally specify a range for this assessment.</p><p> </p>
star this property answering member constituency North Norfolk remove filter
star this property answering member printed Norman Lamb more like this
star this property question first answered
less than 2014-05-06T12:00:00.00Zmore like thismore than 2014-05-06T12:00:00.00Z
star this property answering member
1439
star this property label Biography information for Norman Lamb more like this
star this property tabling member
427
unstar this property label Biography information for Mr Stephen O'Brien more like this
48283
star this property registered interest false more like this
star this property date less than 2014-04-10more like thismore than 2014-04-10
star this property answering body
Department of Health more like this
star this property answering dept id 17 remove filter
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, pursuant to the Answer of 24 March 2014, Official Report, column 120W, on haemolytic uraemic syndrome, for what reasons it was felt that further advice was needed on the overall cost implications, benefits and affordability of eculizumab; when it was first concluded that such further advice was needed; for what reasons the seeking of that advice was delayed until the National Institute for Health and Care Excellence took on responsibility for assessing highly specialised technologies; and if he will make a statement. more like this
star this property tabling member constituency Eddisbury more like this
star this property tabling member printed
Mr Stephen O'Brien more like this
star this property uin 196427 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2014-05-06more like thismore than 2014-05-06
unstar this property answer text <p>Ministers concluded that further advice was needed on the overall cost implications, benefits and affordability of eculizumab as, while Advisory Group for National Specialised Services (AGNSS) members were convinced of the clinical effectiveness of the drug, they noted the very high costs of the drug and the increasing cost profile for the National Health Service.</p><p> </p><p>AGNSS was informed of this decision on 17 January 2013. On 7 February 2013, the Department conveyed its decision to the National Institute for Health and Care Excellence (NICE) so that NICE could begin preparatory work in advance of taking on formal responsibility for evaluating highly specialised technologies on 1 April 2013.</p><p> </p><p>While NICE carries out its evaluation, the current interim commissioning arrangements by NHS England in line with the ‘Clinical Commissioning Policy Statement: Eculizumab for atypical haemolytic uraemic syndrome' will remain in place. The policy statement is available at:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/09/e03-hss-a.pdf</p><p> </p>
star this property answering member constituency North Norfolk remove filter
star this property answering member printed Norman Lamb more like this
star this property question first answered
less than 2014-05-06T12:00:00.00Zmore like thismore than 2014-05-06T12:00:00.00Z
star this property answering member
1439
star this property label Biography information for Norman Lamb more like this
star this property tabling member
427
unstar this property label Biography information for Mr Stephen O'Brien more like this